⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Parker Waichman LLP Files Lawsuit on behalf of Pennsylvania Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Wegovy
prnewswire.com
NVO
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
Parker Waichman LLP Files Lawsuit on behalf of Florida Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic and Mounjaro
prnewswire.com
NVO
LLY
Felix Offers Ozempic at Generic-Level Pricing as Lower-Cost GLP-1 Demand Remains Elevated Across Canada
globenewswire.com
NVO
Gala Health: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support
globenewswire.com
NVO
LLY
The 'Hidden' Side Effect of Weight-Loss Drugs That Could Be Affecting Your Mouth, warns Oralieve
prnewswire.com
NVO
LLY
GLP-1 Receptor Agonist Market Projected to Reach USD 307 Billion by 2035 Driven by Expanding Metabolic Disease Burden – SNS Insider
globenewswire.com
LLY
NVO
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
BioTools Innovator 2026 Cohort Includes Top 30 Life Science Tools and Diagnostics Companies
businesswire.com
TMO
ABBV
DHR
ILMN
NVO
QNRX
XBIO
Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke
globenewswire.com
NVO